Paul Tudor Jones's TYRA Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 16,284 shares of Tyra Biosciences, Inc. (TYRA) worth $623,677, representing 0.00% of the portfolio. First purchased in 2024-Q3, this short-term holding has been held for 7 quarters.
Based on 13F filings, Paul Tudor Jones has maintained this position in TYRA for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 16,284 shares. Largest reduction occurred in Q3 2025, reducing 15,504 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Tyra Biosciences (TYRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Tyra Biosciences (TYRA) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +16,284 | New Buy | 16,284 | $38.30 |
| Q4 2025 | -10,761 | Sold Out | 0 | $0.00 |
| Q3 2025 | -15,504 | Reduce 59.03% | 10,761 | $13.99 |
| Q2 2025 | +14,172 | Add 117.19% | 26,265 | $9.57 |
| Q1 2025 | -3,484 | Reduce 22.37% | 12,093 | $9.30 |
| Q4 2024 | -10,769 | Reduce 40.88% | 15,577 | $13.90 |
| Q3 2024 | +26,346 | New Buy | 26,346 | $23.51 |
Paul Tudor Jones's Tyra Biosciences Investment FAQs
Paul Tudor Jones first purchased Tyra Biosciences, Inc. (TYRA) in Q3 2024, acquiring 26,346 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Tyra Biosciences, Inc. (TYRA) for 7 quarters since Q3 2024.
Paul Tudor Jones's largest addition to Tyra Biosciences, Inc. (TYRA) was in Q3 2024, adding 26,346 shares worth $619,394.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 16,284 shares of Tyra Biosciences, Inc. (TYRA), valued at approximately $623,677.
As of the Q1 2026 filing, Tyra Biosciences, Inc. (TYRA) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Tyra Biosciences, Inc. (TYRA) was 26,346 shares, as reported at the end of Q3 2024.